Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review
30/08/2016
/
Publications
/
Toxicity
A systematic review examined clinical outcomes and toxicities of proton therapy for gastrointestinal neoplasms. The findings include that proton therapy was...
FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification.
07/12/2021
/
Publications
/
FLASH Therapy
Hypofractionation
Another study by the group from New York Proton Center (ProBeam) assessed the feasibility of FLASH RT using single-energy transmission PBS plans of 4.5 Gy × 15...
Treating gastrointestinal malignancy with proton therapy
01/10/2016
/
White Paper
/
Toxicity
Dosimetry
Chemotherapy
The improved dosimetry with proton therapy enables greater sparing of normal tissues...
Dose-escalated PT with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer
13/06/2022
/
Publications
This study by the Jacksonville group reported treatment outcomes of proton therapy for pancreatic cancer. 15 patients received 40.5 GyRBE in 18 fractions to the...
Trends in radiotherapy administration in the management of hepatocellular carcinoma
13/09/2022
/
Publications
/
Survival
Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma...
Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
13/09/2022
/
Publications
/
IMPT
Pencil Beam Scanning - PBS
The paper published by the group from New York Proton Center reported successful PBS Bragg peak FLASH planning for on 10 consecutive hepatocellular carcinoma...
Proton Therapy for Prostate Cancer: Current Status & Future Directions
14/09/2022
/
Webinar
During ISOP 2022, Andrew Lee presented "Proton Therapy for Prostate Cancer: Current Status & Future Directions".
Watch the webinar above.
Proton Therapy for GI Cancers
14/09/2022
/
Webinar
During ISOP 2022, Michael Chuong presented The Proton Therapy for GI Cancers. Watch the webinar above.
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade.
15/11/2022
/
Publications
/
Survival
This study by the NCC group Korea reported results of PBT as an initial treatment for 46 treatment-naïve hepatocellular carcinoma (HCC) patients. With a median...
The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer
15/11/2022
/
Publications
A study by the Samsung group Korea reported outcomes of 49 patients with pancreatic cancer (≥80% patients locally advanced unresectable disease) treated with...
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.
iba-campus- cookies-consent
Used for cookie consent to comply with GDPR.
SESS(followed by a long string of characters)
Drupal user session cookie
VISITOR_INFO1_LIVE
This cookie is set by Youtube to keep track of user preferences for Youtube videos embedded in sites; it can also determine whether the website visitor is using the new or old version of the Youtube interface.
_ga
This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports. By default it is set to expire after 2 years, although this is customisable by website owners.
_ga_Q8N0175HHW
set by Google Analytics
_hjAbsolute SessionInProgress
The cookie is set so Hotjar can track the beginning of the user's journey for a total session count. It does not contain any identifiable information.
_hjIncludedInPageviewSample
This cookie is set to let Hotjar know whether that visitor is included in the data sampling defined by your site's pageview limit.
_hjIncludedInSessionSample
This cookie is set to let Hotjar know whether that visitor is included in the data sampling defined by your site's pageview limit.
_hjSessionUser_xxxxxx
Hotjar cookie that is set when a user first lands on a page with the Hotjar script. It is used to persist the Hotjar User ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
visitor_id#####
This is a cookie pattern that appends a unique identifier for a website visitor, used for tracking purposes. The cookies is set by pardot.com and have a lifespan of 10 years.
lpv928513
Cookie set by pi.pardot.com
YSC
This cookie is set by YouTube to track views of embedded videos. The main purpose of this cookie is: Performance